MyJournals Home  

RSS FeedsPharmaceuticals, Vol. 14, Pages 1053: Mucin1 and Mucin16: Therapeutic Targets for Cancer Therapy (Pharmaceuticals)

 
 

17 october 2021 14:08:40

 
Pharmaceuticals, Vol. 14, Pages 1053: Mucin1 and Mucin16: Therapeutic Targets for Cancer Therapy (Pharmaceuticals)
 


The mucin (MUC) family is a group of highly glycosylated macromolecules that are abundantly expressed in mammalian epithelial cells. MUC proteins contribute to the formation of the mucus barrier and thus have protective functions against infection. Interestingly, some MUC proteins are aberrantly expressed in cancer cells and are involved in cancer development and progression, including cell growth, proliferation, the inhibition of apoptosis, chemoresistance, metabolic reprogramming, and immune evasion. With their unique biological and structural features, MUC proteins have been considered promising therapeutic targets and also biomarkers for human cancer. In this review, we discuss the biological roles of the transmembrane mucins MUC1 and MUC16 in the context of hallmarks of cancer and current efforts to develop MUC1- and MUC16-targeted therapies.


 
156 viewsCategory: Medicine, Pharmacology
 
Pharmaceuticals, Vol. 14, Pages 1051: Identification of Novel Anthracycline Resistance Genes and Their Inhibitors (Pharmaceuticals)
Pharmaceuticals, Vol. 14, Pages 1052: Synthesis, Computational Analysis, and Antiproliferative Activity of Novel Benzimidazole Acrylonitriles as Tubulin Polymerization Inhibitors: Part 2 (Pharmaceuticals)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

Pharmacology


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Nachrichten